X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Journal of Cancer Research and Therapeutics

期刊標題檢索 J CANCER RES TH 最新評論: Did it succeed later? (2024-06-27)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Journal of Cancer Research and Therapeutics]您好,您是該頁面的第 63460 位訪客。

期刊簡介
期刊名稱Journal of Cancer Research and Therapeutics Journal of Cancer Research and Therapeutics
LetPub Score
4.9
50 ratings
Rate

Reputation
5.5

Influence
3.8

Speed
7.8

期刊簡稱J CANCER RES THER
ISSN0973-1482
E-ISSN0974-1127
h-index30
CiteScore
CiteScoreSJRSNIPCiteScore Rank
1.800.4270.535
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Radiology, Nuclear Medicine and Imaging
Q3222 / 333
Category: Medicine
Subcategory: Oncology
Q3277 / 404

自引率 (2023-2024)21.40%自引率趨勢
掲載範囲
The journal will cover technical and clinical studies related to health, ethical and social issues in field of Medical oncology, radiation oncology, medical imaging, radiation protection, non-ionising radiation, radiobiology. Articles with clinical interest and implications will be given preference.
官方網站http://www.cancerjournal.net/
在線稿件提交http://www.cancerjournal.net/submitarticle.asp
開放訪問Yes
出版商Wolters Kluwer Medknow Publications
主題領域ONCOLOGY
出版國/地區INDIA
發行頻率四半期刊行
創刊年0
每年文章數434每年文章數趨勢
黃金OA百分比93.08%
Web of Science 四分位
2023-2024
WOS Quartile: Q4

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ4263/322
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0973-1482%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 6 Month(s)
競爭力 *來自作者的數據: About 95%
參考鏈接
相關期刊 【Journal of Cancer Research and Therapeutics】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE645742
    BIOMATERIALS601407
    Frontiers in Pharmacology504180
    BIOMEDICINE & PHARMACOTHERAPY498667
    JOURNAL OF ETHNOPHARMACOLOGY497081
    Journal of Materials Chemistry B476183
    Frontiers in Immunology461449
    COMPUTERS IN BIOLOGY AND MEDICINE420858
    COLLOIDS AND SURFACES B-BIOINTERFACES419559
    Frontiers in Oncology415910
  •  

    Journal of Cancer Research and Therapeutics Journal of Cancer Research and Therapeutics
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)
  [Journal of Cancer Research and Therapeutics] 的評論撰寫評論
作者: 墟散剑博


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-27 19:25:50 評論於
Did it succeed later?
(0) 讚! | 墟散剑博

作者: 墟散剑博


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-27 11:45:49 評論於
Why are there so few submissions to this magazine?
(0) 讚! | 墟散剑博

作者: SCI文章翻译润色发表


領域: 医学
審稿時間: 10.0 month(s)
結果: 修改後接受


撰寫評論

2024-05-15 15:56:43 評論於
The customer's article was finally accepted after two and a half years of intermittent submission. This magazine is very slow, so please consider carefully before submitting
(0) 讚! | SCI文章翻译润色发表

作者: SCI文章翻译润色发表


領域: 医学
審稿時間: 10.0 month(s)
結果: 修改後接受


撰寫評論

2024-05-15 15:55:05 評論於
Please translate the following paragraph into English and Japanese, and title them as ":" and ":":

This website can be accessed at https://journals.lww.com/cancerjournal/pages/default.aspx
(0) 讚! | SCI文章翻译润色发表

作者: 通幽安雁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-24 21:52:47 評論於
The submission has been under process for 2 months, and emails sent to the editor have failed to deliver as the recipient's mailbox is full and cannot receive new emails. Do any of you have any experience in dealing with this?
(0) 讚! | 通幽安雁

作者: 通幽盼凝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-22 10:28:36 評論於
May I ask if payment is required the first time I submit an article to this magazine, or only after it has been accepted? I did not understand the author guidelines for the journal
(0) 讚! | 通幽盼凝

作者: 晓博大叔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-16 11:29:52 評論於
Withdrawal cannot erase any rubbish stuff
(0) 讚! | 晓博大叔

作者: 俊晤桑


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-14 21:56:52 評論於
Is there an official website for the magazine? I can't find the official website for the magazine
(0) 讚! | 俊晤桑

作者: 晓博大叔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-06 15:57:22 評論於
I am also under process, can I still submit for review? How did you handle it later?
(0) 讚! | 晓博大叔

作者: 晓博大叔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-06 11:16:28 評論於
Is it speaking the truth or being sarcastic?
(0) 讚! | 晓博大叔

作者: 鱼飞


領域: 医学
審稿時間: 1.0 month(s)
結果: 拒稿


撰寫評論

2024-01-14 23:14:43 評論於
The lung nodule prediction model was not accepted
(0) 讚! | 鱼飞

作者: 华清端丽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-13 08:06:47 評論於
What journal did you finally submit to?
I also want to graduate using it
(0) 讚! | 华清端丽

作者: 贝贝小哥哥


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-19 18:24:02 評論於
Invested in November 2022, still under review in September 2023
(0) 讚! | 贝贝小哥哥

作者: 风啸戈雅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-07 21:40:32 評論於
I have been in Peer-Review for several months now, and I have no idea what's going on
(0) 讚! | 风啸戈雅

作者: 风啸戈雅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-07 20:57:44 評論於
I submitted this paper in March 2023, and it's still in Peer-Review in September. It's been more than 4 months maintaining this status, so frustrating
(0) 讚! | 风啸戈雅

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-07 10:18:37 評論於
"In Peer-Review" means that your paper has been submitted to multiple peers for review. This is part of the common submission process, and you can try contacting the journal's editorial office for more information
(0) 讚! | 上清雨真

作者: Accepted-


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-03 17:46:53 評論於
I can't receive emails when registering an account on the official website of this journal, what should I do?
(0) 讚! | Accepted-

作者: Accepted-


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-03 17:45:40 評論於
I can't receive the email when registering an account on the official website of this journal
(0) 讚! | Accepted-

作者: 吴小才


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-09 20:35:44 評論於
Email stated that the email delivery to the following recipient or group failed:

Journal of Cancer Research and Therapeutics (admin@cancerjournal.net)
The recipient's mailbox is full and cannot accept emails at this time. Please try resending your email later, or contact the recipient directly.
Is there anyone else in the same situation as me, should I withdraw my submission?
(0) 讚! | 吴小才

作者: 努力啊大端敏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-09 08:27:38 評論於
It has been under process all along, when will it finally change?
(0) 讚! | 努力啊大端敏

作者: 削月烨赫


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-22 15:50:45 評論於
Review speed: 12.0 | Submission hit rate: 75.0
Experience sharing: After submitting APC, I am unable to submit payment information on the webpage after remittance. Has anyone encountered this situation? What should I do? I also cannot send emails
(0) 讚! | 削月烨赫

作者: 削月烨赫


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-22 12:23:10 評論於
Did you get the final invoice? How did you get it?
(0) 讚! | 削月烨赫

作者: 九阳嘉祯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-19 08:24:42 評論於
This is a good magazine, everyone come and contribute
(0) 讚! | 九阳嘉祯

作者: 魔都浩博


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-05 21:08:07 評論於
Submitted in April 22, still under external review! I strongly advise all friends to retreat, be cautious!!!
(0) 讚! | 魔都浩博

作者: 七伤芳林


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-13 13:19:18 評論於
Do you have any news about your article? Is it a Chinese magazine or an Indian one?
(0) 讚! | 七伤芳林

首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)

開始撰寫 [Journal of Cancer Research and Therapeutics] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*